Price $7.54 |
Market Cap
58.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
38.7
|
P/B
-
|
P/S
1.83
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
11.7
|
Op. Cash Flow
6K
|
FCF
0.6
|
|
Op. Margin
13.80%
|
Net Margin
4.60%
|
ROE
-16.70%
|
ROI
94.90%
|
|
ROA
3.50%
|
EPS Growth
299.90%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Novelion Therapeutics Inc (USA (NVLN) | $1.00 | - | - | 12.9M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $22.86 | - | - | 7.58B | Strong Buy |
| MTBC Inc (MTBC) | $4.11 | - | - | 53.9M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.75 | - | - | 8.7M | Strong Buy |
| Genesis Healthcare Inc (GEN) | $1.32 | - | - | 176.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
